Sandra E. Dillahunt

Array ( [id] => 9538299 [patent_doc_number] => 20140162947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'Kruppel-like Factor 10 (KLF10) as a Biomarker of Endothelial Progenitor Cell Dysfunction' [patent_app_type] => utility [patent_app_number] => 14/003852 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12259 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953356 [patent_doc_number] => 20140356377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'COMPOUNDS FOR USE IN BOOSTING COAGULATION' [patent_app_type] => utility [patent_app_number] => 14/240903 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173942 [patent_doc_number] => 20130315927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'PCSK9 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/984785 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24241 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222938 [patent_doc_number] => 20140017713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'METHOD OF DIAGNOSING CANCER AND DIAGNOSIS KIT USING MEASUREMENT OF NK CELL ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/985301 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9961 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295252 [patent_doc_number] => 20140038886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'HYDROPHOBIC MODIFIED PEPTIDES AND THEIR USE FOR LIVER SPECIFIC TARGETING' [patent_app_type] => utility [patent_app_number] => 13/984694 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15634 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427058 [patent_doc_number] => 08703128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Methods of modulating TGFβ signaling' [patent_app_type] => utility [patent_app_number] => 13/355798 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 11562 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13355798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134372 [patent_doc_number] => 20130295086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'ANTIBODIES SELECTIVE FOR CELLS PRESENTING EGFR AT HIGH DENSITY' [patent_app_type] => utility [patent_app_number] => 13/821832 [patent_app_country] => US [patent_app_date] => 2012-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13570 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302155 [patent_doc_number] => 20120184713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Compositions and Methods for Modulation of Bone Density and Biomineralization' [patent_app_type] => utility [patent_app_number] => 13/353717 [patent_app_country] => US [patent_app_date] => 2012-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14117 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13353717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9204961 [patent_doc_number] => 20140004137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'IMMUNE RESTRICTED PEPTIDES WITH INCREASED EFFICACY' [patent_app_type] => utility [patent_app_number] => 13/992526 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10316 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9211605 [patent_doc_number] => 20140010782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'ANTIBACTERIAL AGENT FOR TREATING INFECTIOUS DISEASES OF BACTERIAL ORIGIN' [patent_app_type] => utility [patent_app_number] => 13/994631 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15141 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197664 [patent_doc_number] => 20130336979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'DIAGNOSTIC AND TREATMENT OF CHRONIC HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/990813 [patent_app_country] => US [patent_app_date] => 2011-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 11273 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13990813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239793 [patent_doc_number] => 20120148528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 13/291838 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12300 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13291838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059414 [patent_doc_number] => 08545849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Stable and soluble antibodies' [patent_app_type] => utility [patent_app_number] => 13/278500 [patent_app_country] => US [patent_app_date] => 2011-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 22076 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13278500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138575 [patent_doc_number] => 20120093833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'Human Oncostatin M Antibodies and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/269976 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22027 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093833.pdf [firstpage_image] =>[orig_patent_app_number] => 13269976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13154001 [patent_doc_number] => 10093712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-09 [patent_title] => Immunostimulatory compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 13/270010 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14578 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13270010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212702 [patent_doc_number] => 20140011879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'SERUM MARKERS FOR IDENTIFICATION OF CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS' [patent_app_type] => utility [patent_app_number] => 13/825060 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13766 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055913 [patent_doc_number] => 20120077690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'BIOMARKERS OF RENAL INJURY' [patent_app_type] => utility [patent_app_number] => 13/235005 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26766 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077690.pdf [firstpage_image] =>[orig_patent_app_number] => 13235005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990352 [patent_doc_number] => 20130217633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'INHIBITORS OF BCL-2' [patent_app_type] => utility [patent_app_number] => 13/819980 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15716 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228426 [patent_doc_number] => 20120142632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'DIAGNOSTIC AND PROGNOSTIC ASSAY' [patent_app_type] => utility [patent_app_number] => 13/198115 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13675 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13198115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8915875 [patent_doc_number] => 20130177500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'ANTI-DESPR INHIBITORS AS THERAPEUTICS FOR INHIBITION OF PATHOLOGICAL ANGIOGENESIS AND TUMOR CELL INVASIVENESS AND FOR MOLECULAR IMAGING AND TARGETED DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/811485 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 64572 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811485 [rel_patent_id] =>[rel_patent_doc_number] =>)